A carregar...
Comparison of fingolimod and dimethyl fumarate in the treatment of multiple sclerosis: Two-year experience
BACKGROUND: Fingolimod (FTY) and dimethyl fumarate (DMF) are multiple sclerosis (MS) oral therapies that became available in 2010 and 2013, respectively. OBJECTIVE: The objective of this article is to compare discontinuation rates, efficacy, and adverse events (AEs) of FTY and DMF over two years. ME...
Na minha lista:
| Publicado no: | Mult Scler J Exp Transl Clin |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5564884/ https://ncbi.nlm.nih.gov/pubmed/28839949 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2055217317725102 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|